These include the formation of a mucin barrier surrounding tumor cells, which serves as a physical shield against therapeutic agents and immune responses, the suppression of apoptotic signaling pathways, p53 downregulation, and the inhibition of ligand expression necessary for immune cell activation in the tumor microenvironment. The gene discussed is MUC5AC; the disease is neoplasm.